← Leaderboards
Andrew Tomaras
Forge Therapeutics, Inc.
$10,977,909
Attributed
$10,977,909
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.3M · FY2022–24$10M$7.5M$5M$2.5M$0
'22
'23
'24
Funding mix
By agency
NIH$10,977,909 · 1
By mechanism
N01$10,977,909 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Pre-Clinical”
- Nancy Jean Sullivan · Boston University Medical Campus$34,500,000
- Taleen Hanania · Psychogenics, Inc.$21,254,211
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Chris Maxwell · National Institute Of Allergy And Infectious Diseases$12,000,000
Research focus
Pre-ClinicalChemistryProduct DevelopmentResearch And DevelopmentEfficacy EvaluationSafety AssessmentTherapeutic CandidateEmerging Communicable DiseasesAdvanced DevelopmentCombating Antibiotic Resistant BacteriaLead OptimizationManufactureMulti-Drug ResistanceNational Institute Of Allergy And Infectious DiseasePathogenPathway InteractionsPriority PathogenResearch SupportTherapeutic DevelopmentUrinary Tract InfectionAntibiotic ResistanceAntimicrobial Resistant InfectionBacterial Drug ResistanceBacterial Resistance